ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 706989 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 706989; 2) Community: the network communities that were significantly associated with the response to NSC 706989; 3) Molecule: the relationships between components within communities and NSC 706989; 4) MDR: the compounds that were significantly associated with the NSC 706989.

NSC Compound Enrichment Correlation
NSC 304421 LEUROSINE-N-OXIDE 0.00306027196853058 0.18366851
NSC 341196 Null 0.00306027196853058 0.06746471
NSC 382028 Maxima isoflavone D 0.00306027196853058 0.033015122
NSC 646848 Bengamide H 0.00306027196853058 0.015467354
NSC 668482 Null 0.00306027196853058 -0.181409
NSC 684909 2,6-Pyrimidinediamine, 4-chloro-5-[(4-chlorophenyl)azo]- N(6)-[[1-(hydroxymethyl)-3-(phenylmethoxy)cyclobutyl] methyl]-, (Isomer A)-, stereoisomer of NSC-684910 0.00306027196853058 -0.1377366
NSC 708240 Cbz-[Lys3]-Didemnin B 0.00306027196853062 0.39310186
NSC 736099 Null 0.00306027196853062 -0.081153414
NSC 685126 4-Piperidinone, 3,5-bis[(4-fluorophenyl)methylene]-, (E,E)- 0.00347157511980532 0.02405906
NSC 616348 Irinotecan hydrochloride 0.00404192617431249 0.19185322
Total:57  Current:4    [First] [Prev] [Next] [Last]